Legal & General Group Plc acquired a new stake in shares of Aurora Cannabis Inc (NYSE:ACB) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 573,404 shares of the company’s stock, valued at approximately $2,847,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in ACB. Flagship Harbor Advisors LLC purchased a new position in shares of Aurora Cannabis during the fourth quarter valued at approximately $26,000. Trustcore Financial Services LLC purchased a new stake in Aurora Cannabis during the fourth quarter valued at approximately $33,000. Farmers & Merchants Trust Co of Chambersburg PA purchased a new stake in Aurora Cannabis during the fourth quarter valued at approximately $36,000. Beutel Goodman & Co Ltd. purchased a new stake in Aurora Cannabis during the fourth quarter valued at approximately $37,000. Finally, Baldwin Brothers Inc. MA purchased a new stake in Aurora Cannabis during the fourth quarter valued at approximately $40,000. 8.66% of the stock is owned by hedge funds and other institutional investors.
A number of analysts have commented on ACB shares. Jefferies Financial Group started coverage on shares of Aurora Cannabis in a report on Monday, February 25th. They set a “buy” rating for the company. Seaport Global Securities started coverage on shares of Aurora Cannabis in a report on Thursday, February 21st. They set a “neutral” rating for the company. Cowen started coverage on shares of Aurora Cannabis in a report on Tuesday, March 5th. They set an “outperform” rating for the company. GMP Securities raised shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a report on Wednesday, March 13th. Finally, ValuEngine raised shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a report on Tuesday, March 19th. One analyst has rated the stock with a hold rating and four have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $9.50.
Shares of ACB stock opened at $8.51 on Tuesday. Aurora Cannabis Inc has a 12 month low of $4.05 and a 12 month high of $12.52. The company has a market cap of $9.00 billion, a price-to-earnings ratio of 63.43 and a beta of 2.98. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.31 and a quick ratio of 2.50.
Aurora Cannabis (NYSE:ACB) last announced its earnings results on Monday, February 11th. The company reported ($0.04) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.06) by $0.02. Aurora Cannabis had a negative net margin of 57.54% and a positive return on equity of 3.95%. The business had revenue of $41.00 million during the quarter. As a group, research analysts predict that Aurora Cannabis Inc will post -0.17 earnings per share for the current year.
WARNING: This piece of content was reported by Macon Daily and is owned by of Macon Daily. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at https://macondaily.com/2019/04/16/legal-general-group-plc-takes-position-in-aurora-cannabis-inc-acb.html.
Aurora Cannabis Profile
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Want to see what other hedge funds are holding ACB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aurora Cannabis Inc (NYSE:ACB).
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.